Showing results (831-840 of 932) with videos related to

Sort By:
Pageof 94
Cancer Research|February 7, 2007
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737Stephen K Tahir, Xiufen Yang, Mark G Anderson, et al.
Bioorganic & Medicinal Chemistry|January 30, 2007
Design and synthesis of pyridine-pyrazolopyridine-based inhibitors of protein kinase B/AktGui-Dong Zhu, Jianchun Gong, Viraj B Gandhi, et al.
Journal of Medicinal Chemistry|December 2, 1999
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activityK J Henry, J Wasicak, A S Tasker, et al.
Annals of Neurology|January 15, 2009
Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsyRenata C Gallagher, Johan L K Van Hove, Gunter Scharer, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitorsZhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Cell Reports|December 6, 2018
HDAC3 Regulates the Transition to the Homeostatic Myelinating Schwann Cell StateLaura H Rosenberg, Anne-Laure Cattin, Xavier Fontana, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailabilityYunsong Tong, Nan-Horng Lin, Le Wang, et al.
Neoplasia (New York, N.Y.)|December 8, 2005
Optimal classes of chemotherapeutic agents sensitized by specific small-molecule inhibitors of akt in vitro and in vivoYan Shi, Xuesong Liu, Edward K Han, et al.
Plos One|July 25, 2022
Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancerLisanne S Rigter, Petur Snaebjornsson, Efraim H Rosenberg, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2013
Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative propertiesMathieu Bibian, Ronald J Rahaim, Jun Yong Choi, et al.
Pageof 94